Level C· Early human research exploring benefitsProspective StudyPubMedOpen access

Multidisciplinary management of bronchoesophageal fistula using adipose-derived stromal vascular fraction and platelet-rich plasma.

van Dongen JA., Pouw RE., Bülbül M., Kemming HJL., Coert JH., Hillegersberg RV.

Prospective Study on Autoimmune Research, published in VideoGIE (2025) — summary generated from the PubMed abstract.

Open my reading list
Level C· Early human research exploring benefitsEvidence level of this study

Early human evidence such as case series or small samples is exploring possible benefits.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Prospective Study
Journal
VideoGIE (2025)
Country
United States
Reported sample size
—
Source database
PubMed
PMID
41727389
PMCID
PMC12921678
DOI
10.1016/j.vgie.2025.09.007

Abstract (original English)

Background and aims Bronchoesophageal fistula (BEF) is a rare but life-threatening adverse event following surgery. Fistulas result in respiratory adverse events, often requiring surgical repair, which is a high-risk procedure. Therefore, minimally invasive alternatives are needed. We aimed to use adipose-derived stromal vascular fraction (SVF) to treat BEFs. Methods We present 2 BEF cases after minimally invasive esophagectomy and gastric conduit reconstruction. During the procedure, SVF was isolated and platelet-rich plasma (PRP) obtained. In 1 case with a tracheaesophageal fistula, simultaneous bronchoscopy and endoscopy were performed to localize and treat the fistula; in the second case, only gastroscopy was performed to treat a fistula from the esophagus to the right upper lobe. During the procedures, the epithelialized fistula tract was cleared using brushing and argon plasma coagulation, followed by injection of SVF-PRP around the fistula. Closure was obtained using a through-the-scope suturing system. Results The patients recovered well, and an esophagram 4 weeks postprocedure showed no more signs of a fistula. Currently, 7 and 4 months postprocedure, respectively, both patients are on a normal oral diet and with restored pulmonary function. Conclusions These cases demonstrate that SVF-PRP injection combined with endoscopic closure may offer a promising minimally invas

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Early human evidence such as case series or small samples is exploring possible benefits.

How we grade evidence

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research